RKIP

PF3D7_1219700 (RKIP) is a phosphatidylethanolamine-binding protein (PEBP)-family member of P. falciparum that functions as a lipid-binding regulator of the calcium-dependent protein kinase PfCDPK1 (PMID:7637711, PMID:39842334). Through its PEBP domain it binds phosphatidic acid and phosphorylated phosphatidylinositol lipids including PtdIns(3)P at physiological pH, an interaction that depends on conserved PEBP-domain residues and on a distinctive IKK motif whose mutation reduces lipid binding (PMID:39842334). RKIP physically associates with PfCDPK1 both in vitro and within the parasite (PMID:39842334): as both a substrate and a regulator of the kinase, its presence enhances PfCDPK1 autophosphorylation while suppressing phosphorylation of competing substrates (PMID:17123645). Upon addition of a PfCDPK1 substrate, the kinase hyper-phosphorylates RKIP, driving RKIP dissociation and relieving inhibition so that PfCDPK1 can trans-phosphorylate downstream substrates — a substrate-competition regulatory switch operative during asexual schizogony (PMID:39842334). Beyond this PfCDPK1-regulatory role and its lipid-binding activity, no further cellular function of RKIP has been characterized in the available corpus.

1. 1995 Low

   Establishing what kind of protein PF3D7_1219700 is: sequence determination placed it in the phosphatidylethanolamine-binding protein (PEBP) family, framing all subsequent lipid- and kinase-related hypotheses.

   Evidence Primary structure determination and sequence analysis in P. falciparum

   PMID:7637711

   Open questions at the time

   • No functional assay; family assignment is sequence-based only
   • No demonstration of lipid binding or any partner at this stage
2. 2006 Medium

   Testing whether RKIP has a functional relationship to a parasite kinase: in vitro assays showed it is a PfCDPK1 substrate and, more importantly, a modulator that boosts kinase autophosphorylation while dampening phosphorylation of other substrates.

   Evidence Recombinant protein expression, purification, and in vitro kinase assays with purified proteins

   PMID:17123645

   Open questions at the time

   • Interaction shown only in vitro, not in the parasite
   • Structural basis of the regulatory effect unresolved
   • Physiological consequence of the regulation not tested
3. 2007 Medium

   Determining the structural framework of the protein: a 1.3 Å ortholog structure confirmed the PEBP fold but revealed a distinctive left-handed alpha-helical element beside the canonical phospholipid-binding site, defining a structurally distinct PEBP subfamily.

   Evidence X-ray crystallography (MAD, 1.3 Å) of the P. vivax RKIP ortholog

   PMID:17329808

   Open questions at the time

   • Structure is of the P. vivax ortholog, not the P. falciparum protein itself
   • Functional role of the distinctive helical motif not tested by mutagenesis
   • No ligand bound in the structure
4. 2025 Medium

   Defining the lipid-binding activity implied by the PEBP fold: RKIP binds phosphatidic acid and phosphorylated phosphatidylinositols via conserved PEBP residues and a unique IKK motif, giving the family assignment concrete biochemical meaning.

   Evidence Lipid-binding assays, site-directed mutagenesis, and in silico docking in P. falciparum

   PMID:39842334

   Open questions at the time

   • Physiological lipid ligand in vivo not established
   • Link between lipid binding and PfCDPK1 regulation not directly tested
   • Single lab
5. 2025 High

   Resolving how RKIP regulates PfCDPK1 mechanistically and whether the interaction occurs in cells: RKIP interacts with PfCDPK1 in vitro and in the parasite, and substrate-driven hyper-phosphorylation of RKIP triggers its dissociation, establishing a substrate-competition switch that relieves inhibition of downstream substrate phosphorylation.

   Evidence ELISA, immunofluorescence, proximity biotinylation (BioID), and in vitro kinase assays in P. falciparum

   PMID:39842334

   Open questions at the time

   • Downstream PfCDPK1 substrates released by the switch not identified
   • In-parasite functional consequence of RKIP loss not tested (no knockout/knockdown phenotype)
   • Single lab

• Whether RKIP is essential for asexual development and how its lipid binding is coupled to PfCDPK1 regulation in vivo remain unresolved.
• No genetic loss-of-function phenotype for RKIP reported
• Physiological trigger and biological output of the substrate-competition switch unknown
• Relationship between membrane lipid binding and kinase regulation untested